DENTSPLY SIRONA (NASDAQ:XRAY) Shares Gap Up After Analyst Upgrade

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) gapped up before the market opened on Thursday after Bank of America upgraded the stock from a neutral rating to a buy rating. The stock had previously closed at $12.49, but opened at $13.12. Bank of America now has a $17.00 price target on the stock, up from their previous price target of $13.00. DENTSPLY SIRONA shares last traded at $12.7270, with a volume of 1,296,946 shares traded.

XRAY has been the subject of a number of other reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research note on Wednesday, January 21st. JPMorgan Chase & Co. decreased their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research note on Friday, November 7th. Mizuho upped their target price on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research note on Tuesday, January 20th. Barclays initiated coverage on DENTSPLY SIRONA in a report on Monday, December 8th. They issued an “underweight” rating and a $12.00 price target on the stock. Finally, Stifel Nicolaus set a $13.00 price objective on DENTSPLY SIRONA in a report on Thursday, November 6th. Three analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $14.46.

Insider Activity

In other news, Director Gregory T. Lucier sold 82,200 shares of the firm’s stock in a transaction on Monday, December 8th. The stock was sold at an average price of $11.14, for a total transaction of $915,708.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.50% of the company’s stock.

Key DENTSPLY SIRONA News

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: Bank of America upgraded XRAY from Neutral to Buy and raised its price target to $17 from $13 (about 35.6% upside vs. the current price). The upgrade is being cited as the primary catalyst for intraday gains. B of A Securities Upgrades DENTSPLY SIRONA (XRAY) Dentsply Sirona gains as BofA upgrades to Buy on risk-reward setup
• Neutral Sentiment: The company is expected to announce quarterly earnings on Thursday, which increases near-term volatility and focus on results vs. guidance. Investors should watch the report for revenue trends and margin commentary. DENTSPLY SIRONA (XRAY) Expected to Announce Earnings on Thursday
• Neutral Sentiment: Short-interest data reported in the last two days shows anomalous figures (zeros/NaN), suggesting a reporting error rather than a true surge in shorting; this makes short-interest-driven moves unlikely unless corrected data emerges.
• Negative Sentiment: A Zacks preview warns that XRAY lacks the setup for an earnings beat in the coming report, which could cap upside and lead to a pullback if results or guidance disappoint. Traders should weigh the upgrade optimism against this caution. Dentsply International (XRAY) Earnings Expected to Grow: What to Know Ahead of Next Week’s Release

Institutional Investors Weigh In On DENTSPLY SIRONA

Several large investors have recently modified their holdings of the business. Eurizon Capital SGR S.p.A. bought a new position in shares of DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in DENTSPLY SIRONA during the 1st quarter valued at $26,000. Parkside Financial Bank & Trust boosted its position in DENTSPLY SIRONA by 620.6% during the 2nd quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,477 shares in the last quarter. Huntington National Bank increased its holdings in shares of DENTSPLY SIRONA by 292.9% in the 3rd quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 2,077 shares during the period. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 2,122 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 0.2%

The business has a 50 day moving average of $12.23 and a two-hundred day moving average of $12.49. The stock has a market capitalization of $2.50 billion, a PE ratio of -2.84, a PEG ratio of 0.98 and a beta of 1.01. The company has a debt-to-equity ratio of 1.36, a quick ratio of 0.99 and a current ratio of 1.47.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.64 dividend on an annualized basis and a yield of 5.1%. DENTSPLY SIRONA’s dividend payout ratio is presently -14.48%.

DENTSPLY SIRONA Company Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.